Danaher Corp (WBO:DHRC)
€ 228.85 1.5 (0.66%) Market Cap: 165.29 Bil Enterprise Value: 179.42 Bil PE Ratio: 46.05 PB Ratio: 3.40 GF Score: 86/100

Danaher Corp Bioprocessing Analyst & Investor Day Transcript

Sep 15, 2022 / 03:00PM GMT
Release Date Price: €255.35 (+2.16%)
John Bedford
Danaher Corporation - VP of IR

Good morning, everybody. I guess good afternoon. We just turned to 12:00 here. So thank you all for coming here. We got a full crowd here. I'm sure we have a full crowd on the webcast here. It's been 3 years since we've been in person. So we're really excited here to welcome you all to Cytiva and learn a little bit more about the our bioprocessing business, and Rainer will be up here to make some opening remarks shortly as well. Before we get started, I have to read. Today's presentation may include forward-looking statements, and actual results may differ materially from these statements. Please refer to the slide show and in our website for more information here.

With that, again, have a really great day here for you. We're going to start, Rainer is going to come up and make some opening remarks, certainly commenting a little bit on the news from last night. We'll then go to Biotechnology Group here where Emmanuel Ligner and team will really give you a little bit more look under the hood of the great businesses that we have here with Pall and Cytiva,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot